BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 32030723)

  • 21. Topical management of actinic keratosis and field cancerisation.
    Stockfleth E
    G Ital Dermatol Venereol; 2009 Aug; 144(4):459-62. PubMed ID: 19755950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skin Cancers in Medicare Beneficiaries With Actinic Keratoses.
    Mohr C; Li Y; Navsaria LJ; Hinkston CL; Shete SS; Margolis DJ; Wehner MR
    JAMA Dermatol; 2023 Dec; 159(12):1368-1372. PubMed ID: 37938822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ten-Year Follow-up of Persons With Sun-Damaged Skin Associated With Subsequent Development of Cutaneous Squamous Cell Carcinoma.
    Madani S; Marwaha S; Dusendang JR; Alexeeff S; Pham N; Chen EH; Han S; Herrinton LJ
    JAMA Dermatol; 2021 May; 157(5):559-565. PubMed ID: 33760003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of Ingenol Mebutate in the Treatment of Actinic Keratoses: A Pre- and Posttreatment Dermoscopic Comparative Analysis.
    Carbotti M; Coppola R; Zanframundo S; Devirgiliis V; Panasiti V
    Biomed Res Int; 2018; 2018():4381019. PubMed ID: 30246021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Natural History of Actinic Keratosis and Cutaneous Squamous Cell Carcinoma Microbiomes.
    Wood DLA; Lachner N; Tan JM; Tang S; Angel N; Laino A; Linedale R; Lê Cao KA; Morrison M; Frazer IH; Soyer HP; Hugenholtz P
    mBio; 2018 Oct; 9(5):. PubMed ID: 30301852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Daylight Photodynamic Therapy for Actinic Keratoses.
    Morton CA; Braathen LR
    Am J Clin Dermatol; 2018 Oct; 19(5):647-656. PubMed ID: 29752702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensified fractional CO2 laser-assisted photodynamic therapy vs. laser alone for organ transplant recipients with multiple actinic keratoses and wart-like lesions: a randomized half-side comparative trial on dorsal hands.
    Helsing P; Togsverd-Bo K; Veierød MB; Mørk G; Haedersdal M
    Br J Dermatol; 2013 Nov; 169(5):1087-92. PubMed ID: 23855503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment-resistant actinic keratoses are characterized by distinct clinical and histological features.
    Schmitz L; Brehmer A; Falkenberg C; Gambichler T; Heppt MV; Steeb T; Gupta G; Malvehy J; Dirschka T
    Ital J Dermatol Venerol; 2021 Apr; 156(2):213-219. PubMed ID: 33960752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing management of actinic keratosis and photodamaged skin: utilizing a stepwise approach.
    Lee AD; Jorizzo JL
    Cutis; 2009 Sep; 84(3):169-75. PubMed ID: 19842577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized split-scalp study comparing calcipotriol-assisted methyl aminolaevulinate photodynamic therapy (MAL-PDT) with conventional MAL-PDT for the treatment of actinic keratosis.
    Torezan L; Grinblat B; Haedersdal M; Valente N; Festa-Neto C; Szeimies RM
    Br J Dermatol; 2018 Oct; 179(4):829-835. PubMed ID: 29476546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy Assessment of the High-Frequency High-Intensity Focused Ultrasound as a New Treatment for Actinic Keratosis.
    Seyed Jafari SM; Cazzaniga S; Bossart S; Feldmeyer L; Pelloni L; van Rhyn M; Angermeier S; Adatto M; Hunger RE; Heidemeyer K
    Dermatology; 2022; 238(4):662-667. PubMed ID: 34933303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Actinic Keratosis and Cutaneous Squamous Cell Carcinoma.
    Gutzmer R; Wiegand S; Kölbl O; Wermker K; Heppt M; Berking C
    Dtsch Arztebl Int; 2019 Sep; 116(37):616-626. PubMed ID: 32048593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted deep sequencing reveals genomic alterations of actinic keratosis/cutaneous squamous cell carcinoma in situ and cutaneous squamous cell carcinoma.
    Kim YS; Jung SH; Park YM; Park GS; Kim HS; Maeng LS; Chung YJ
    Exp Dermatol; 2023 Apr; 32(4):447-456. PubMed ID: 36533870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Actinic keratoses contiguous with squamous cell carcinomas are mostly non-hyperkeratotic and with severe dysplasia.
    Heerfordt IM; Poulsen T; Wulf HC
    J Clin Pathol; 2022 Aug; 75(8):560-563. PubMed ID: 33863749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Healthcare utilization and management of actinic keratosis in primary and secondary care: a complementary database analysis.
    Noels EC; Hollestein LM; van Egmond S; Lugtenberg M; van Nistelrooij LPJ; Bindels PJE; van der Lei J; Stern RS; Nijsten T; Wakkee M
    Br J Dermatol; 2019 Sep; 181(3):544-553. PubMed ID: 30636037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 2: Commonly used field-directed and lesion-directed therapies.
    Berman B; Cohen DE; Amini S
    Cutis; 2012 Jun; 89(6):294-301. PubMed ID: 22838095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tirbanibulin for the Treatment of Actinic Keratosis: A Review.
    Miller AC; Adjei S; Temiz LA; Tyring SK
    Skin Therapy Lett; 2022 Jul; 27(4):4-7. PubMed ID: 35857917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of facial predilection sites for cutaneous squamous cell carcinoma and actinic keratosis in Japanese patients.
    Shibayama Y; Imafuku S
    J Dermatol; 2014 Dec; 41(12):1102-5. PubMed ID: 25385075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cryosurgery combined with topical interventions for actinic keratosis: a systematic review and meta-analysis.
    Heppt MV; Steeb T; Ruzicka T; Berking C
    Br J Dermatol; 2019 Apr; 180(4):740-748. PubMed ID: 30447074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The importance of treating the field in actinic keratosis.
    Stockfleth E
    J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():8-11. PubMed ID: 28263021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.